|
Market Closed -
NYSE
16:00:02 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 229.94 USD | -9.05% |
|
-9.06% | -4.54% |
| 10-30 | RBC Raises Price Target on ResMed to $288 From $262, Keeps Outperform Rating | MT |
| 10-30 | Citigroup Adjusts Price Target on ResMed to $270 From $240 | MT |
Chart calendar ResMed, Inc.
Upcoming events on ResMed, Inc.
| 2026-11-12 | Ex-dividend date - 0.66 USD | 00:00 |
| 2026-11-17 | Annual General Meeting | |
| 2026-11-18 | Présentation aux Actionnaires / Analystes | 18:00 |
Past events on ResMed, Inc.
| 2026-10-29 | Earnings release - Q1 2027 | |
| 2026-10-29 | Earnings presentation | 16:30 |
| 2026-08-06 | Earnings presentation | 16:30 |
| 2026-08-06 | Earnings release - Q4 2026 | |
| 2026-04-30 | Earnings release - Q3 2026 | |
| 2026-04-30 | Earnings presentation | 16:30 |
| 2026-01-29 | Earnings release - Q2 2026 | |
| 2026-01-29 | Earnings presentation | 16:30 |
| 2025-11-19 | Présentation aux Actionnaires / Analystes | 18:00 |
| 2025-11-19 | Annual General Meeting | 18:00 |
Past dividends on ResMed, Inc.
| 2026-08-20 | Ex-dividend date - 0.66 USD | 00:00 |
| 2026-05-14 | Ex-dividend date - 0.6 USD | 00:00 |
| 2026-02-12 | Ex-dividend date - 0.6 USD | 00:00 |
| 2025-11-13 | Ex-dividend date - 0.6 USD | 00:00 |
Annual results
| Fiscal Period | June | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4 685 4 678 0.16% | 5 146 5 128 0.36% | 5 653 5 648 0.09% | 5 835 | 6 197 | 6 582 |
|
EBITDA Million USD | Released Forecast Spread | 1 576 1 577 -0.1% | 1 884 1 862 1.18% | 2 329 2 213 5.25% | 2 269 | 2 421 | 2 596 |
|
EBIT Million USD | Released Forecast Spread | 1 478 1 462 1.13% | 1 763 1 738 1.45% | 2 039 2 039 0.02% | 2 112 | 2 268 | 2 441 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 265 1 280 -1.2% | 1 678 1 669 0.53% | 1 919 1 936 -0.84% | 2 115 | 2 271 | 2 442 |
|
Net income Million USD | Released Forecast Spread | 1 021 1 023 -0.23% | 1 401 1 364 2.69% | 1 523 1 541 -1.12% | 1 670 | 1 797 | 1 936 |
|
EPS USD | Released Forecast Spread | 6,92 6,99 -1.06% | 9,51 9,31 2.2% | 10,4 10,6 -1.5% | 11,8 | 12,9 | 14,3 |
| Announcement Date | 01/08/24 | 31/07/25 | 06/08/26 | - |
Quarterly results
| Fiscal Period | June | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 | 2028 Q2 | 2028 Q3 | 2028 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 282 1 267 1.18% | 1 292 1 284 0.58% | 1 348 1 331 1.31% | 1 336 1 333 0.2% | 1 423 1 398 1.76% | 1 431 1 422 0.63% | 1 464 1 461 0.21% | 1 415 1 393 1.55% | 1 456 | 1 460 | 1 498 | 1 468 | 1 546 | 1 550 | 1 590 |
|
EBITDA Million USD | Released Forecast Spread | 464 463 0.2% | 470 474 -0.87% | 519 495 4.86% | 510 509 0.28% | 547 551 -0.6% | 559 558 0.07% | 584 582 0.42% | 528 512 3.1% | 568 | 588 | 607 | 562 | 628 | 643 | 659 |
|
EBIT Million USD | Released Forecast Spread | 436 429 1.68% | 445 439 1.36% | 476 456 4.52% | 482 471 2.34% | 517 507 2.05% | 525 519 1.11% | 515 528 -2.48% | 506 471 7.53% | 522 | 534 | 553 | 533 | 564 | 570 | 595 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 418 408 2.59% | 418 421 -0.89% | 458 445 3.01% | 447 455 -1.84% | 496 491 1.01% | 502 508 -1.13% | 474 519 -8.6% | 539 463 16.33% | 515 | 523 | 551 | 523 | 565 | 569 | 599 |
|
Net income Million USD | Released Forecast Spread | 345 328 4.95% | 365 338 7.98% | 380 354 7.23% | 349 357 -2.4% | 393 387 1.32% | 399 399 0% | 383 404 -5.07% | 418 368 13.68% | 410 | 416 | 429 | 399 | 444 | 451 | 468 |
|
EPS USD | Released Forecast Spread | 2,34 2,23 5.14% | 2,48 2,29 8.32% | 2,58 2,41 7.25% | 2,37 2,44 -2.97% | 2,68 2,64 1.64% | 2,74 2,72 0.7% | 2,64 2,81 -5.98% | 2,92 2,59 12.95% | 2,92 | 3,05 | 3,14 | 3,04 | 3,20 | 3,30 | 3,41 |
| Announcement Date | 30/01/25 | 23/04/25 | 31/07/25 | 30/10/25 | 29/01/26 | 30/04/26 | 06/08/26 | 29/10/26 | - | - | - | - | - | - | - |
| 2026-11-02 |  | Information meeting | 20:00 |
| 2026-11-03 | | Earnings presentation | 08:00 |
| 2026-11-03 | | Earnings release - Q3 2026 | |
| 2026-11-03 | | Earnings release - Q3 2026 | |
| 2026-11-03 | | Earnings presentation | 04:00 |
| 2026-11-03 | | Earnings presentation | 07:30 |
| 2026-11-03 | | Earnings release - Q3 2026 | |
| 2026-11-03 | | Earnings presentation | 16:30 |
| 2026-11-03 | | Earnings release - Q3 2026 | |
| 2026-11-03 | | Présentation aux Actionnaires / Analystes | 19:01 |
Past sector events for ResMed, Inc.
| Today | | Earnings release - Q3 2026 | |
| 2026-10-30 | | Earnings release - Q3 2026 | |
| 2026-10-30 | | Earnings release - Q3 2026 | |
| 2026-10-29 | | Earnings presentation | 16:30 |
| 2026-10-29 | | Earnings release - Q3 2026 | |
| 2026-10-29 | | Earnings presentation | 08:00 |
| 2026-10-29 | | Earnings release - Q3 2026 | 08:00 |
| 2026-10-29 | | Earnings release - Q2 2027 | |
| 2026-10-29 | | Earnings release - Q3 2026 | 02:30 |
| 2026-10-29 | | Earnings presentation | 11:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
- Calendar ResMed, Inc.
Select your edition
All financial news and data tailored to specific country editions
